Australia Platelet Rich Plasma (prp) Market Size & Outlook
Australia platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
Australia platelet rich plasma (prp) market highlights
- The Australia platelet rich plasma (prp) market generated a revenue of USD 6.2 million in 2023 and is expected to reach USD 17.6 million by 2030.
- The Australia market is expected to grow at a CAGR of 16.1% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2023 | USD 6.2 million |
| Market revenue in 2030 | USD 17.6 million |
| Growth rate | 16.1% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Australia accounted for 1.0% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, India platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 90.7 million by 2030.
Pure prp was the largest segment with a revenue share of 46.77% in 2023. Horizon Databook has segmented the Australia platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
PRP has emerged as a promising treatment in regenerative medicine in Australia. Clinics and healthcare providers have praised its benefits, often featuring celebrity endorsements, suggesting that PRP can address various issues, such as chronic pain, hair loss, and wrinkles.
Osteoarthritis, a leading cause of pain and disability in Australia affecting approximately 2 million people, has prompted significant interest in treatments that can alleviate symptoms and potentially slow or reverse disease progression.
A clinical trial conducted by the University of Melbourne demonstrated significant improvement in knee pain over 12 months among those who received PRP injections. In addition, Australian Sports Doctors (ASD) offer PRP injections as part of their services in Melbourne, focusing on assessing and managing musculoskeletal conditions and sports injuries.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
Australia Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
